ReGelTec, Inc. is developing HYDRAFIL™, an injectable hydrogel designed for minimally invasive treatment of chronic low back pain caused by degenerative disc disease. This proprietary technology allows the hydrogel to be injected into the intervertebral disc, where it integrates with existing tissue to restore biomechanical properties and improve patient outcomes with a short recovery time.
Funding
$6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Chronic low back pain resulting from degenerative disc disease significantly impacts patients' quality of life and places a substantial burden on healthcare systems due to frequent healthcare visits and lost productivity. Current treatments often involve invasive procedures and lengthy recovery times, presenting challenges for patients seeking effective and less disruptive solutions.
Solution
ReGelTec is developing HYDRAFIL, an injectable hydrogel designed for minimally invasive treatment of chronic low back pain caused by degenerative disc disease. HYDRAFIL is injected into the intervertebral disc, where it integrates with the existing nucleus and cools to form a solid implant. This integrated solid mimics the biomechanical properties of the natural disc, preserving spinal motion and restoring functionality. Early clinical results indicate significant improvements in back pain with a minimally invasive procedure and short recovery time.
Target Audience
The primary target audience includes individuals suffering from chronic low back pain due to degenerative disc disease, as well as interventional pain specialists and spine surgeons seeking minimally invasive treatment options.
Features
- Injectable hydrogel delivered through a 17-gauge needle for minimally invasive application
- Hydrogel formulation that integrates with the existing disc nucleus to restore biomechanical properties
- Mimics the natural disc's biomechanical properties to preserve spinal motion
- Short recovery time compared to traditional surgical interventions
- Demonstrated significant improvements in back pain in early clinical studies